Bristol-Myers Squibb Company · NYSE:BMY
Bristol-Myers Squibb — Investor Presentation (2012)
27 slides from Bristol-Myers Squibb's investor presentation, 2012
Slide 1: Panel IV: Pursuing Population Health Impact through Geospatial Mapping and Community-Clinic Connections
Panel IV: Pursuing Population Health Impact through Geospatial Mapping and Community-Clinic Connections Expert Faculty: George Rust, Morehouse School of Medicine
Slide 2: Together on Diabetes: Mapping Solutions for the Mississippi Delta
Together on Diabetes: Mapping Solutions for the Mississippi Delta Anna Lyn Whitt, LMSW, MPH Mississippi Public Health Institute Panel IV: Pursuing Population Health Impact through Geospatial Mapping and Community-Clinic Connections
Slide 3: Project Description
Project Description • Planning grant – 08/11—12/12 – Discovery: best practice for diabetes care in local practices – Discovery: how people with diabetes feel about diabetes and diabetic care – Discovery: what providers and policy makers think about diabetes – Dissemination: share the information we
Slide 4: Project Progress: Interim Process and Health Outcome Results
Project Progress: Interim Process and Health Outcome Results • GIS Mapping of Diabetes in the Delta • Staff hired: Medical Director; Nutritionist; Project Manager (Social Worker) • Partnerships established • Learning Collaborative Efforts – Literature reviews – BRFSS – Process and narratives establi
Slide 5: Lessons Learned
Lessons Learned • In addition to asset mapping, we need to problem map • What are the contributors to such poor health?
Slide 6: Challenges
Challenges • Disjointed efforts with competing priorities • Limited resources force us to compete • Short time investments – long term solutions • Perceived priorities – health? • Respecting culture while improving health
Slide 7: Key Next Steps
Key Next Steps • Continue to engage stakeholders • Complete Qualitative Data • Learning Collaborative – Fellow Grantees • Disseminate and Share • Build a plan from the community up • Combine efforts to join resources • Fill gaps identified by the community • Promote PCMH
Slide 8: The More We Know; the More We Can Do!
The More We Know; the More We Can Do!
Slide 9: Durham Diabetes Collaborative
Durham Diabetes Collaborative Marie Lynn Miranda, Ph.D. On behalf of Durham County Health Department, Duke University, and the University of Michigan Panel IV: Pursuing Population Health Impact through Geospatial Mapping and Community-Clinic Connections
Slide 10: Central Objectives
Central Objectives • Improve population-level DM management, health outcomes, and quality of life for diagnosed and undiagnosed adults living with T2DM. • Reduce disparities in diabetes management, health outcomes, and quality of life for adults living with T2DM. These include disparities based on r
Slide 11: Spatially-enabled data architecture and feedback loops
Spatially-enabled data architecture and analytics (who, what, where) COMMUNITY PARTNERSHIP CLINICAL Feedback loop Feedback loop ZONE CARE Decision support systems Accountability: real-time monitoring and evaluation (e.g., weight, HbA1c, vision, CVD, cancer, nutrition, nephropathy, neuropathy, physic
Slide 12: Duke Patient Data Warehouse
Duke Patient Data Warehouse • In Durham County, 215,731 unique patients have been geocoded (80% of Durham County population) • 14,245 of the geocoded patients have a DM dx (6.7% of total; 55% African American, 56% female, 87% 40 years old or above) • Of the diabetic patients, 10,775 (76%) have had a
Slide 13: Percent Diabetes Patients
Percent Diabetes Patients HbA1C Lab Out of Range Percent Diabetes Patients Percent Duke Patients with Diabetes No HbA1C Lab Recorded [] 2.44% - 4.65% 4.66% - 6.39% HE 6.4% - 7.42% HE 7 43% - 9.37% HH 9.28% - 18.39% [_] 9.09% - 19.53% [19.54% - 22.86% HE 22.87% - 25.13% HM 25.14% - 28.81% HM 28.82% -
Slide 14: East Durham Diabetes Patients
i East Durham Diabetes Patients 2007 Diabetes Patients 2008 Diabetes Patients 2009 Diabetes Patients Count: 379 Count: 382 Count: 445 Mean Age: 55 Mean Age: 54 Mean Age: 54 84% African American 87% African American 80% African American 13% White 13% White 13% White 65% Female 67% Female 62% Female 6
Slide 15: Duke Diabetes Patients
Duke Diabetes Patients “ly Percent Out of Range 18.64% - 31.15% J] 31.16% - 33.44% I 33.45% - 35.82% —— I | 35.83% - 40% re) 40.01% - 55.17% ml =) Central Durham Neighborhoods| i hee fl | BE Fors \ B j @ Liquor Stores \ b } oe 7 A Grocery Stores GB Pharmacies @ Fast Food
Slide 16: Medical-Social Risk Phenotypes
Medical-Social Risk Phenotypes monthly data extract Missing + risk algorithms data Lower intensity Higher intensity Intervention Spectrum
Slide 17: Key Next Steps
Key Next Steps • New complete data pull covering key metrics • Continue community relationship-building • Establish data sharing relationship with FQHC • Define and map phenotypes • Identify intervention neighborhoods • Implement tailored interventions
Slide 18: Integrated Diabetes Care
Integrated Diabetes Care Steven Kaufman, MD Camden Coalition of Healthcare Providers Panel IV: Pursuing Population Health Impact through Geospatial Mapping and Community-Clinic Connections
Slide 19: Where the Healthcare Home fits in
Where the Healthcare Home fits in Hospital • Multidisciplinary care management outreach Admission • Patients with history of ED visits/hospital admissions and readmissions (4 admits w/in 6 mos.); social s Data complexities • Average 6-8 month engagement CCHP Outreach Camden PCP High Risk Care Coordi
Slide 20: Healthcare Cost Hotspots in Camden, NJ (Jan 2002-June 2008)
Healthcare Cost Hotspots in Camden, NJ (Jan 2002-June 2008) Northgate II isits, 615 patients $83 million in charge ($21,000 per visit) $12 million in receipts 15% collection rate Abigail House 1,414 visits, 332 patients $92 million in charges ($65,000 per \ $15 million in rece’ 16% collection r Over
Slide 21: Building Level Analysis
Building Level Analysis Northgate II $12 million in receipts over 5 year perio
Slide 22: Project Progress: Interim Process and Health Outcome Results
Project Progress: Interim Process and Health Outcome Results • DSME • Decision Support • Teachable Moments • Shared group visits • Project DULCE • Support groups / Patient Engagement • EHR • HIE
Slide 23: Lessons Learned
Lessons Learned • Even the idea of change can be daunting • Limited fiscal and human resources restrict a practices ability to make change • Team collaboration • Easy to focus on healthy individuals • This is hard work
Slide 24: What does it look like?
What does it look like? CDE LPN Project/Clinical Nurse Care Social Work Management DCA/Health Coordinator Coaches Patient Engagement Programmatic Work Care Coordination Community Resources Phase 2 20 high-risk patients Phase 1 RN/LPN High Utilizers
Slide 25: Challenges
Challenges Lack of patient registries Healthcare culture that patients are non- compliant/unwilling to change behaviors Primary care practices’ ability to see themselves as an agent of change Incorporation of resources into the practice Dysfunctional practice dynamics interfering with collabora
Slide 26: Key Next Steps
Key Next Steps • Months 1-6 • Form RN/LPN Team • Care coordination – Targeting sickest patients w/ high ED and IP admissions – Coordinate care of patient between time of discharge to PCP visit » RN/LPN hand –off to PCP » PCP visit Nurse provides f/u care – Panel Building – Getting the PCP to know
Slide 27: Camden Primary Care Practice
CCHP Camden Provides resources and support to work towards Primary Care a patient-centered Practice medical home Practice Quality Management Improvement Program IDC Core Team • Nurse Care Coordinator Care Coordination Manager • LPN • Diabetes Care Advocate • Program Assistant Sub-acute Patient Care
Bristol-Myers Squibb Company — Investor Presentation (2012) on 6ix